Taipei, March 26 (CNA) Taiwan's Industrial Technology Research Institute (ITRI) signed a memorandum of understanding (MOU) with German pharmaceutical and life science giant Merck on Monday on cooperation to developed advanced biopharma technologies.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
- Society
New Taipei infant daycare center fined for mistreating child
06/09/2023 10:55 PM - Society
More high-profile figures accused as Taiwan's #MeToo movement spreads
06/09/2023 10:43 PM - Business
Taiwan's GlobalWafers chair named EY World Entrepreneur of the Year
06/09/2023 10:35 PM - Cross-Strait